Objective. Moderate alcohol consumption has been associated with improved health outcomes including reduced risk of heart disease; however, less is known regarding alcohol's effects on chronic pain. The aim of this study was to assess associations between pain, fibromyalgia symptoms, and moderate alcohol use in a large chronic pain sample.
Introduction
Alcohol use is common and socially acceptable among adults in the United States, with more than half (56%) of all US adults reporting drinking alcohol at least once per month [1] . Alcohol is a central nervous system (CNS) depressant that acts on multiple important neurotransmitter systems, including the gamma-aminobutyric acid (GABA), serotonin, glutamate, and endogenous opioidergic systems [2] . Alcohol consumption has both positive and negative health effects associated with its use.
Previous studies [3] [4] [5] have suggested that moderate consumption of alcohol (one drink/d for women; two drinks/d for men) has cardio-protective effects, including decreased risk of coronary heart disease and ischemic stroke. Alcohol consumption exhibits J-shaped and U-shaped effects on life expectancy (total mortality), where those drinking low-to-moderate amounts of alcohol (one or two drinks/d) have a decreased risk of mortality and those consuming more than three drinks per day have an increased risk [6] [7] [8] . Furthermore, moderate alcohol consumption has been associated with reduced risk of diabetes [5] and dementia [9, 10] , fewer depressive symptoms [11] , and increased cognitive function [12, 13] , physical function [14] , and quality of life or well-being [8, 11, 13, 15] .
The National Institute on Alcoholism and Alcohol Abuse (NIAAA) [16] considers drinking more than seven and 14 drinks per week for women and men, respectively, to be "heavy" drinking. Heavy drinkers are at risk for injury, development of alcohol use disorder, and a myriad of negative health effects. Heavy drinking has been associated with increased risk of liver disease, heart disease, depression, diabetes, obesity, and impaired cognitive function [17] [18] [19] .
While much is known regarding the positive and negative health effects of moderate and heavy alcohol use in the general population, less is known about the potential health benefits and/or risks associated with moderate drinking habits in chronic pain patients. More than 25 million adults in the United States suffer from daily chronic pain [20] , and approximately a quarter of these individuals use alcohol to manage their pain [21] .
Studies investigating alcohol's effects on pain [22, 23] suggest a dose-dependent relationship, with lower consumption levels typically related to improved pain outcomes. In low back pain patients [23] , moderate drinking was associated with less disability. Other studies have shown that regular alcohol consumption compared with seldom or no drinking is associated with reduced pain severity in rheumatoid arthritis [24] , and moderate drinking is protective against the development of chronic widespread pain [25, 26] but does not appear to affect its persistence [27] . Recent studies also showed benefits of low to moderate alcohol consumption in fibromyalgia patients, including decreased severity of fibromyalgia symptoms and disability and higher quality of life compared with no alcohol consumption [28, 29] . Together, these studies suggest a protective effect of low-risk drinking on pain outcomes.
The aim of this study was to assess associations between pain, fibromyalgia symptoms, physical function, and mood with moderate (low-risk) alcohol use in a large sample of mixed chronic pain patients. To corroborate previous findings in FM, a subset of patients meeting FM survey criteria were also examined against patients not meeting FM criteria. Consistent with previous findings, we hypothesized that moderate alcohol consumption would be associated with less pain and lower symptom severity in both chronic pain patients and the subset of patients with FM.
Methods

Patient Recruitment
New patients presenting to a university-based pain clinic completed a battery of validated questionnaires and a survey of medication and substance use. Patients were provided documentation informing them that a waiver of consent was obtained and that their deidentified survey data could be used for research purposes. Patients were informed that they could opt out of participation in the research use of these data. Collection and analysis of these data were approved by the Institutional Review Board (IRB) at the University of Michigan (Ann Arbor, MI, USA).
Study Design and Alcohol Group Classifications
Patients were dichotomized into alcohol drinkers and nondrinkers. Alcohol consumption was patient-reported via the survey battery and prompted by the question "Do you drink alcohol?"; if "yes," patients then reported the number of drinks consumed per day. One drink was defined as 12 fluid ounces of beer (5% alcohol), 5 fluid ounces of wine, or one shot (1.5 fluid ounces of distilled alcohol). Drinks per day were converted to drinks per week for ease of interpretation with previous studies.
Alcohol-consuming patients were classified as moderate drinkers (females: seven drinks or less/wk; males: 14 drinks or less/wk) or heavy drinkers (females: eight drinks or more/wk; males: 15 drinks or more/wk) according to the recommendations of the 2015-2020 Dietary Guidelines for Americans [30] and NIAAA guidelines [16] for "low-risk" and "at-risk" alcohol drinking habits, respectively. The resulting group of heavy drinkers (3.5% of the total sample) was excluded from further analyses due to the small sample size. Adjusted mean symptom levels for heavy drinkers are shown in the Supplementary Data.
We also performed analyses stratified by gender, due to established relationships with alcohol metabolism, and by clinical FM status, to determine if relationships between clinical measures and moderate alcohol consumption differed by the presence of a pain condition with well-established CNS alterations in the processing of pain and neurotransmitter systems that interact with alcohol consumption [31, 32] .
Self-report Measures
Fibromyalgia Symptoms
The 2011 survey criteria for FM [33] were used for FM status classification and to assess the magnitude of FM-like symptoms in all patients [34] [35] [36] . The survey criteria consist of the widespread pain index (WPI), where patients indicate the spatial extent or "widespreadness" of their pain using a 19-site body map, and the symptom severity (SS) subscale (0-12), which queries the presence of lower abdominal pain/cramps, depression, and headache, and the severity of three nonspecific central nervous system symptoms: fatigue, unrefreshing sleep, and cognitive dysfunction. When added together, the WPI and SS represent a patient's FM severity score or his/her degree of "fibromyalgia-ness" (FMness) [37] , where scores range from 0 to 31 on a continuous scale and higher scores indicate increased FM severity or FMness. Scoring criteria for categorization [33] of a patient as meeting FM survey criteria are as follows: WPI 7 and SS 5 or WPI ¼ 3-6 and SS 9.
Pain Severity and Pain-Related Interference
The Brief Pain Inventory (BPI) was used to assess clinical pain experience and includes two (0-10) subscales: pain severity and pain interference [38] . The pain severity subscale assesses four aspects of pain intensity (worst, least, average, and current pain). The pain interference subscale assesses the degree to which pain interferes with life activities (general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life) over the previous week. All items are rated 0-10, and higher scale scores are indicative of increased pain severity and interference.
Physical Function
The 10-item PROMIS Physical Function 10a short-form [39] assessed physical limitations (vigorous activity, walking, climbing stairs, lifting, and bending) and difficulties in functional daily activities (bathing, dressing, housework, and yard work). Items are individually scored by five-point Likert scales and then summed for the raw score. Raw scores are converted to standardized t-scores with a mean of 50 and standard deviation of 10. Higher scores indicate better function.
Psychological Measures
Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS). The survey has two seven-item subscales, with scores ranging from 0 to 21, with higher scores indicating greater symptoms. Scores 11 on either subscale are considered a "case" of anxiety or depression [40] . Catastrophizing or negative thinking as a reaction to pain was measured with the six-item catastrophizing subscale [41] of the Coping Strategies Questionnaire (CSQ-CAT). Scores range from 0 to 36, and higher scores are indicative of greater pain catastrophizing.
Statistical Analysis
Distributions for all continuous data were assessed for normality via histogram and quantile-quantile (Q-Q) plot examination. Missing data were handled according to recommendations from each measure's author(s). Associations between moderate vs no alcohol consumption and symptoms were assessed using a general linear model (GLM) analysis; univariate analysis was used to determine model covariates using Pearson's chi-square (X 2 ) test and one-way analysis of variance (ANOVA) for categorical and continuous variables, respectively. Covariates included in the model were selected based on statistical significance of P < 0.05 and clinical relevance. Potential covariates included age, gender, race, education, living situation, smoking, and opioid use. Categorical variables are reported as frequency (%). Continuous scores for self-report measures are reported as marginal mean 6 standard error; all other continuous variables (e.g., age, drinks/wk) are reported as mean 6 standard deviation. Paired marginal mean difference 6 SE are reported as x. Secondary analyses, stratified by gender and clinical FM status [37] , were performed using the same GLM approach. All analyses were performed using IBM SPSS 22 (Armonk, NY, USA).
Results
This study consisted of 2,583 chronic pain patients (58% female) with a mean age of 50.73 6 15.61 years. Patients were predominately white (86%) and of nonHispanic origin (87%). The sample was well educated, with 35% having a Bachelor's degree or higher and another 33% having completed some college or technical school. More than half of patients (52%) reported opioid analgesic use, with 18% of opioid users also reporting alcohol use. Of the 2,493 eligible (excluding heavy drinkers, N ¼ 90) chronic pain patients, 1,991 (77%) reported no alcohol use and 502 (19%) were classified as moderate drinkers (Table 1) .
Moderate Alcohol Use in Chronic Pain Patients
Moderate drinkers reported drinking a mean of 4.54 6 3.62 drinks per week (females: 3.24 6 2.27; males: 5.64 6 4.15 drinks/wk). Univariate analysis revealed significant differences between nondrinkers and moderate drinkers in gender (X 2 ¼ 37. 28, all P < 0.0001); groups did not differ in age (P ¼ 0.778). Compared with chronic pain patients who do not drink, moderate drinkers were more likely to be male, white, and highly educated, and less likely to smoke and use opioids (Table 1) . Marginal means for independent measures are shown in Table 2 and Figure 1 . After controlling for significant covariates, GLM analysis revealed significant effects on all independent measures, where moderate drinking was associated with a significantly lower FM score (paired marginal mean difference, x ¼ 1.11 6 0.29), including lower scores on both the symptom severity (x ¼ 0.51 6 0.16) and widespread pain index (x ¼ 0.61 6 0. 20) subscales, lower pain severity (x ¼ 0.47 6 0.09) and interference (x ¼ 0.57 6 0.11), lower anxiety (x ¼ 0.66 6 0.24), depression (x ¼ 1.14 6 0.24), and catastrophizing (x ¼ 2.85 6 0.56), and higher physical function (x ¼ 2.77 6 0.39), compared with nondrinking chronic pain patients (Table 2) . Within the moderate drinking group, patients with lower overall pain intensity (BPI scores 6.5, as determined by median-split) reported drinking slightly more per week than those patients with higher overall pain (BPI scores > 6.5, 4.35 6 0.19 vs 4.86 6 0.25 drinks per week, respectively), although this difference was not significant (P ¼ 0.106).
Moderate Alcohol Use in Gender-Stratified Groups
In the male stratum, moderate drinkers and nondrinkers differed significantly by education (X 2 ¼ 58.97, P < 0.0001), living situation (X 2 ¼ 21.22, P ¼ 0.001), opioid use (X 2 ¼ 27.34, P < 0.0001), and smoking (X 2 ¼ 16.10, P < 0.0001); age (P ¼ 0.123) and race (P ¼ 0.100) did not differ significantly. Compared with male nondrinkers, male moderate drinkers were more likely to be highly educated and living with a spouse or significant other, and less likely to smoke and use opioids. While controlling for sociodemographic differences, GLM analysis revealed that moderate alcohol consumption in males had a significant effect on all outcomes, except anxiety (P ¼ 0.70) (Table 3) . Male moderate drinkers reported lower FM scores (x ¼ 1.21 6 0.38), both in terms of symptom severity (x ¼ 0.74 6 0.21) and widespread pain (x ¼ 0.49 6 0.25), Values reported as frequency (%), unless otherwise indicated; moderate alcohol classification defined as drinking no more than 7 and 14-drinks/wk for females and males, respectively; chi-square (X 2 ) test and analysis of variance assessed categorical and continuous variables, respectively; bold indicates significance at P < 0.05. FM ¼ fibromyalgia; GED ¼ General Equivalency Development. lower pain severity (x ¼ 0.35 6 0.13) and interference in activities (x ¼ 0.54 6 0.15), lower depression (x ¼ 0.71 6 0.34) and catastrophizing (x ¼ 3.18 6 0.80), and higher physical function (x ¼ 2.52 6 0.56), compared with male nondrinkers (Table 3 ).
In the female stratum, moderate drinkers and nondrinkers differed significantly by race (X 2 ¼ 9.74, P ¼ 0.002), education (X 2 ¼ 58.97, P < 0.0001), living situation (X 2 ¼ 13.35, P ¼ 0.020), opioid use (X 2 ¼ 13.11, P < 0.0001), and smoking (X 2 ¼ 6.22, P ¼ 0.013); age (P ¼ 0.107) did not differ. Compared with female nondrinkers, female moderate drinkers were more likely to be white, highly educated, and living with a spouse or significant other, and less likely to smoke and use opioids. Similar to the male stratum, moderate alcohol consumption was related to significant benefits on all outcomes, with the exception of FM symptom severity (P ¼ 0.193) ( Table 3) (Table 3) .
Moderate Alcohol Use in a Subset of Chronic Pain Patients with Fibromyalgia
Of the total chronic pain sample, 891 (35%) patients also met fibromyalgia survey criteria. Within these FM patients, 738 (83%) were nondrinkers and 153 (17%) reported alcohol use, with 131 (86%) classified as moderate drinkers and 22 (14%) as heavy drinkers. The FM subset was mostly female (64%), with many patients reporting opioid use (60%) and a proportion reporting smoking (35%). Patients meeting criteria for FM had a mean age of 47.89 6 13.82 years and reported drinking a mean of 3.61 6 2.89 drinks per week (females: 3.07 6 2.27 drinks/wk; males: 4.27 6 3.43 drinks/wk). Univariate analysis revealed that moderate drinkers and nondrinkers meeting FM survey criteria differed significantly by gender (X 2 ¼ 4.30, P ¼ 0.038), education (X 2 ¼ 21.60, P < 0.0001), and opioid use (X 2 ¼ 13.54, P < 0.0001). Groups did not differ by age (P ¼ 0.688), race (P ¼ 0.418), living situation (P ¼ 0.106), or smoking (P ¼ 0.846). FM moderate drinkers were more likely to be female and highly educated, and less likely to use opioids, compared with nondrinking FM patients. After adjusting for significant covariates, moderate alcohol consumption in FM patients was associated with lower pain severity (x ¼ 0.38 6 0.15), pain interference (x ¼ 0.32 6 0.16), and depression (x ¼ 0.83 6 0.42), and higher physical function (x ¼ 2.19 6 0.59). Moderate and nondrinking patients did not differ in FM score (SS and WPI), catastrophizing, or anxiety. Marginal means for chronic pain patients meeting FM survey criteria are shown in Table 4 .
Moderate Alcohol Use in a Subset of Chronic Pain Patients Without Fibromyalgia
Of the 1,692 (65%) chronic pain patients who did not meet survey criteria for fibromyalgia, 1,253 (74%) were nondrinkers, 371 (85%) classified as moderate drinkers and 68 (15%) as heavy drinkers. Moderate drinking patients without FM reported consuming a mean of 4.87 6 3.79 drinks per week (females: 3.32 6 2.27 drinks/wk; males: 6.01 6 4.26 drinks/wk), which is 1.26 more drinks per week than moderate drinking patients with FM, a difference approaching statistical significance (gender-controlled, P ¼ 0.06). Patients not meeting FM criteria had a mean age of 52.09 6 16.42 years, which did not differ between alcohol groups (P ¼ 0.577). 
Missing Data
Of the independent measures, data were missing for the SS score (0.3%), BPI (2.1%), CSQ-CAT (26.3%), HADS (4.5%), and PROMIS Physical Function (5.1%). Demographic characteristic or covariate data were missing for age (0.3%), race (2.6%), smoking (3.7%), education (2.2%), and living group (2.5%). All data were reported for the FM survey score, WPI, opioid use, and gender.
Discussion
Results from this study suggest that chronic pain patients with low-risk, moderate drinking levels have significantly lower FM symptoms, pain severity and interference, anxiety, depression, and catastrophizing, as well as higher physical function, compared with chronic pain patients who do not consume alcohol. In a subset analysis of patients meeting FM survey criteria, moderate alcohol use was associated with decreased pain severity, pain interference, and depression, and increased physical function, but it did not have an effect on FM symptoms. Conversely, in patients not meeting FM criteria, moderate drinking was associated with significantly lower scores on all pain and symptom outcomes and increased physical function.
Our hypothesis that chronic pain patients who drink moderately would report less pain and symptom severity compared with nondrinkers was supported. Importantly, national guidelines for what constitutes moderate drinking were developed for the prevention of drinkingrelated health and safety risks, and these reflect consumption levels associated with cardiovascular benefits. They were not developed in regards to any potential benefits for pain. Definitive conclusions regarding optimal dose-response relationships between alcohol drinking patterns and chronic pain outcomes cannot be determined until substantial additional research, including prospective studies, is performed. Therefore, current government guidelines for low-risk drinking, including recommendations on when not to drink at all (e.g., during pregnancy, when taking medications that interact with alcohol, if prone to excessive consumption/addiction), should be followed. This is crucial given that chronic pain patients have a higher prevalence of alcohol abuse [22, [42] [43] [44] .
Moderate drinking in patients meeting criteria for FM was associated with decreased pain severity, pain interference, and depression, and higher physical function, compared with nondrinkers. However, contrary to our hypothesis, no significant associations were observed for FM symptoms (FM severity, SS, WPI scores) or anxiety and catastrophizing in FM patients. In chronic pain patients who did not meet FM criteria, results were similar to the total chronic pain sample, with significant differences in all independent measures, including lower FM symptoms. Taken together, these data suggest that chronic pain patients with less centralized pain (i.e., less FMness) may benefit more from moderate alcohol consumption than patients meeting FM classification criteria.
We previously demonstrated that measuring FM symptoms in non-FM patient groups has significant clinical value. In a study of osteoarthritis patients without FM undergoing knee arthroplasty [34] , for every one-point increase in FM score (from 0 to 31), individuals had an adjusted increased risk of 18% for failing to meet the threshold for improvement six months after surgery. Furthermore, we showed that in the immediate inpatient period, individuals undergoing knee arthroplasty or hysterectomy needed 7-9 mg greater oral morphine equivalents for each one-point increase in the FM score, even after adjusting for important covariates of postoperative pain [35, 36] . Less than 9% of participants in these studies met criteria for being classified as FM positive. These data suggest that the effects of moderate alcohol consumption on FM symptoms has important clinical implications for chronic pain patients in general, regardless of FM status.
Our results in FM patients are consistent with those of Macfarlane and Beasley [28] , who showed an association between decreased disability with alcohol consumption in patients with chronic widespread pain. Although we did not measure disability per se, our results show increased physical function with moderate alcohol consumption. In contrast, our results differ from those reported by Kim et al. [29] , where alcohol consumption was shown to have a significant effect on FM symptom severity in FM patients. Within our FM subset, no significant differences in FM severity were found between the no alcohol and moderate drinking groups. Our alcohol groupings differed from those used by Kim et al. [29] , and this could possibly explain the difference in results. Kim et al. [29] used the Fibromyalgia Impact Questionnaire revised (FIQ-R) to measure FM symptom severity and the 1990 ACR criteria [45] to classify fibromyalgia patients, whereas we used the 2011 ACR survey criteria [33] for both purposes. Lastly, our FM sample consisted of a much larger proportion of males. Kim et al. [29] also found improved quality of life (QOL) in low to moderate alcohol consumers. While our study did not include a QOL measure, significantly lower depression was observed in FM patients who drink moderately.
Beyond these methodological considerations, there are other possible explanations for alcohol's reduced effect in FM. One is that these patients have substantially higher FM scores compared with non-FM patients, suggesting a possible ceiling effect for the benefits of alcohol. FM patients also drink slightly less per week than non-FM patients who drink moderately. This lower dose of alcohol could account for the lack of association with these symptoms. Perhaps a more biologically relevant reason relates to the interaction of alcohol and the endogenous opioid system. Our group and others [31, 32] have demonstrated altered endogenous opioid analgesic activity in FM that may be different compared with other chronic pain patients [46] and that suggests a possible reason for why exogenous opiates appear to have reduced efficacy in this population. Opioid receptors have also been shown to contribute to alcohol's effects in the brain [47] . Interestingly, reducing the availability of opioid receptors via pharmacologic antagonism is a widely applied treatment for alcohol abuse [48] , and this in turn suggests one endogenous mechanism by which FM patients may be less responsive to the analgesic effects of alcohol. Additional research is required to answer this question more definitively.
Within the moderate drinking patients, those without FM reported drinking greater amounts of alcohol than those with FM. Similarly, patients with lower overall pain intensity drink somewhat more than those with higher overall pain. Interestingly, both those moderate drinkers without FM and those with lower pain also reported higher income levels (data not reported). Alcohol consumption is often thought of as a means to facilitate social interaction, and although reasons for drinking and drinking pattern (alone or social) were not assessed in this study, a speculative interpretation of these data suggests that a higher income provides more opportunities for socialization, in turn buffering pain symptoms, an effect consistent with previous studies of social interaction and pain [49] . Furthermore, because all psychological symptoms, including depression, anxiety, and catastrophizing, were less severe in moderate drinkers, it is possible that alcohol's analgesic properties mediate the increased psychological function observed in our sample, which increases social interactions.
Studies by our group and others [50] [51] [52] [53] using proton magnetic resonance spectroscopy have revealed an imbalance of excitatory and inhibitory neurotransmitter metabolites in several chronic pain conditions. For example, relative to healthy controls, FM patients exhibit elevated levels of insular glutamate and glutamine (referred to as Glx when combined) and reduced levels of GABA, which are associated with clinical and experimental pain [54] [55] [56] [57] . Furthermore, increased Glx levels in FM patients were rectified by analgesic treatment [58] , suggesting that treatments that reduce excitatory neurotransmission and/or increase inhibitory neurotransmission are potential analgesic targets. Results from the present study showing associations between alcohol consumption and multiple CNS-mediated domains support the notion that alcohol's action as a CNS depressant underlie its analgesic effects, yet multiple negative findings in the fibromyalgia subset suggest a multifaceted mechanism. Acute alcohol administration enhances inhibitory GABAergic neurotransmission and reduces glutamate release and effectiveness at glutamatergic receptors [2, [59] [60] [61] [62] [63] [64] [65] [66] [67] . However, prolonged alcohol administration results in alterations of GABA receptor function related to tolerance and a neuroadaptive upregulation of glutamatergic receptor expression and tone [61, 63, 65, 68, 69] , indicating that the analgesic effects of alcohol may wane over time or that cessation of alcohol use could increase pain symptoms. In alcoholdependent individuals, for instance, there is a considerable but temporary increase in cortical glutamate concentration following alcohol withdrawal that normalizes over a period of one to three months [70, 71] . It is unclear if similar effects on brain excitatory/inhibitory balance occur following long-term moderate alcohol use or if the effects differ in patients with FM. There is evidence that the chronic effects of alcohol on brain chemistry are dependent on the duration, frequency, and amount of past alcohol consumption, as well as other factors including sex, age, and concurrent substance use (i.e., smoking) [62, [72] [73] [74] . Additional research on both the acute and chronic effects of moderate alcohol consumption on brain chemistry in chronic pain patients is warranted.
Several limitations of this study need to be addressed. The cross-sectional nature of this analysis allows for associations to be made between alcohol consumption and clinical outcomes, but causation cannot be determined. Patients self-reported all clinical measures and their level of substance use; social stigmas of appropriate alcohol use, particularly in individuals seeking new chronic pain management, may have biased the results or caused underreporting. Patients were not classified as being life-long abstainers or previous drinkers, as some studies have done. Alcohol consumption was reported as the number of drinks per day, and the type of alcoholic drink was not collected or controlled for; however, the survey instructed patients on what a single alcoholic drink would equate to in terms of beer, wine, and liquor by the shot. Body mass or weight can influence alcohol metabolism, and these data were not available. Alcohol affects the pharmacokinetic metabolism of medications, including opioids. Half our sample was on opioid therapy, with 18% of opioid users reporting concurrent alcohol use. The combination of alcohol and opioids carries potential serious risks, such as increased respiratory depression [75, 76] .
Additional research is also needed in a much larger sample of chronic pain patients who engage in at-risk, heavy alcohol use. Our preliminary supplemental analyses suggest that much of the analgesic effect is preserved in heavy drinkers, but these results should be interpreted with much caution as the sample size was small and most individuals consumed only marginally more alcohol than moderate drinkers. More critically, chronic heavy alcohol consumption is associated with widespread adverse effects in the brain and the periphery implicated in the generation and/or amplification of pain [77] [78] [79] . These include various functional and morphological brain injuries (e.g., cortical and subcortical atrophy) and peripheral neuropathies that can result directly from alcohol intake and indirectly from alcohol's inhibition of nutritional absorption [74, 80] . Skeletal muscle myopathy is a well-established and common consequence of heavy alcohol use that might also contribute to musculoskeletal pain and symptoms in alcohol misusers [81, 82] . Unlike moderate drinking, which may provide protective effects against pain [25, 83] , heavy alcohol consumption is associated with an increased likelihood of having pain [83] [84] [85] , cognitive impairment, increased psychological symptoms, and an overall lower quality of life [80, 86] . Heavy drinking therefore cannot be considered a viable treatment option for chronic pain. Although the present results show improved symptoms in moderate drinkers, we do not recommend that patients alter their drinking habits without first consulting with their health care provider.
Conclusion
This study assessed the relationship between moderate alcohol consumption and symptoms of chronic pain. Female and male chronic pain patients who drink no more than 7 and 14 alcoholic drinks per week, respectively, reported significantly lower FM symptoms, pain severity, pain-related interference in activities, depression, anxiety, and catastrophizing, and higher physical function, compared with chronic pain patients who do not drink alcohol. In both patients who met and patients who did not meet survey criteria for fibromyalgia, moderate alcohol use was associated with significantly lower pain severity, pain-related interference, and depression, and higher physical function. In addition, moderate alcohol consumption was associated with lower anxiety and catastrophizing in non-FM patients. These findings suggest that chronic pain patients with a lesser degree of pain centralization may benefit most from low-risk, moderate alcohol consumption.
